Table 3.
Potential inhibitors of DUBs involved in therapeutic implications in neurodegenerative diseases
| Disease | Compounds | Target protein | Functional implication of the compound | References |
|---|---|---|---|---|
| PD | CMPD-39 | USP30 | Enhance peroxisome turnover and mitophagy | [173] |
| PD | FT3967385 | USP30 | Accelerate PINK1 generation of phospho-Ser65 ubiquitin | [174] |
| AD | IU1 | USP14 | Accelerate tau degradation | [175–177] |
| AD | LDN57444 | UCHL1 | Inhibit tau aggregation and affect APP processing | [178–180] |
| ALS | HBX41108 | USP7 | Inhibit the toxicity of the mutant SOD1 in neurons | [181] |
For each disease, the list is sorted alphabetically by “Compounds”